Thomas Bures SEC EDGAR Filings (CIK 0001787029)

SEC EDGAR filings, ownership reports, and insider transactions for Thomas Bures.

Business address
C/O Pieris Pharmaceuticals, Inc., 255 State Street, 9 Th Floor, Boston, MA, 02109
Top holdings (ownership)
BRKR
Get insider transactions for this reporting owner
Thomas Bures has filed 8 SEC EDGAR filings since 03 Sep 2019

Latest Filings

Recent SEC filings for Thomas Bures including 4, 3.

Form type Document Filing Description Filing date Reporting date File number(s)
4 Open 4 document View SEC filing for 4 11 Mar 2025 10 Mar 2025 000-30833
4 Open 4 document View SEC filing for 4 19 Feb 2025 15 Feb 2025 000-30833
3 Open 3 document View SEC filing for 3 16 Jan 2025 13 Jan 2025 000-30833
4 Open 4 document View SEC filing for 4 230228 FORM 4 (BURES) 28 Feb 2023 24 Feb 2023 001-37471
4 Open 4 document View SEC filing for 4 PRIMARY DOCUMENT 24 Feb 2022 22 Feb 2022 001-37471
4 Open 4 document View SEC filing for 4 PRIMARY DOCUMENT 08 Mar 2021 04 Mar 2021 001-37471
4 Open 4 document View SEC filing for 4 PRIMARY DOCUMENT 02 Mar 2020 27 Feb 2020 001-37471
3 Open 3 document View SEC filing for 3 PRIMARY DOCUMENT 03 Sep 2019 03 Sep 2019 001-37471

About this filer

Thomas Bures files with the SEC under CIK 0001787029. This page aggregates EDGAR filings and related ownership activity.

See reporting owner transactions.

FAQ

What is a CIK?
A Central Index Key (CIK) is a unique identifier assigned by the SEC to each filer.
Why are some filings missing?
New filings appear as the SEC updates EDGAR, and older records can vary by availability.
How often is this page updated?
Updates follow new EDGAR submissions and periodic data refreshes.

Related pages